Jun 1, 2020

Risk of using hydroxychloroquine as a treatment of COVID-19

The International Journal of Risk & Safety in Medicine
Lo'ai AlanagrehManar Atoum

Abstract

The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical data to support the beneficial effect of this drug in COVID-19 treatment. HCQ has several side effects and warnings, including blindness, heart failure, and renal toxicity, even with recommended doses. For severe cases of COVID-19 or in patients with preexisting conditions, administering such a drug could be fatal, particularly when taken at high doses or in combination with other antibiotics. However, further well-designed studies that would address the optimal dose, duration of treatment, possible side effects, and long-term usage outcomes are needed to make the final decision. In this paper, we aim to discuss the risk of using HCQ in treating COVID-19 patients, including its possible side effects.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Antimalarials
Attention
Antibiotics
A 19
Antiviral Therapy
Vaccines
Interleukin 19 Measurement
Pharmacologic Substance
Adverse Effects
Blind Vision

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Cleveland Clinic Journal of Medicine
Emily Littlejohn
The American Journal of Tropical Medicine and Hygiene
Melissa Barreto FalcãoCarlos Alexandre Antunes de Brito
International Neurourology Journal
Khae Hawn Kim
Neurocirugía
Carlos Botella
© 2020 Meta ULC. All rights reserved